BCRX

BioCryst Pharmaceuticals Inc (BCRX)

NASDAQ: BCRXUSD
9.02 USD
-0.20 (-2.16%)
AT CLOSE (11:59 AM EDT)
9.11
+0.09 (+0.99%)
POST MARKET (AS OF 07:59 PM EDT)
🔴Market: CLOSED
Open?$9.31
High?$9.35
Low?$8.92
Prev. Close?$9.02
Volume?7.8M
Avg. Volume?6.5M
VWAP?$9.09
Rel. Volume?1.20x
Bid / Ask
Bid?$7.70 × 100
Ask?$9.03 × 100
Spread?$1.33
Midpoint?$8.37
Valuation & Ratios
Market Cap?2.3B
Shares Out?250.8M
Float?199.1M
Float %?94.6%
P/E Ratio?8.57
P/B Ratio?-18.99
EPS?$1.05
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.06Strong
Quick Ratio?2.03Strong
Cash Ratio?0.46Low
Debt/Equity?-3.93Low
ValuationATTRACTIVELY VALUED
Score
94/100
P/E?
8.6CHEAP
P/B?
-18.99CHEAP
P/S?
2.59CHEAP
P/FCF?
6.6CHEAP
EV/EBITDA?
7.7CHEAP
EV/Sales?
3.02FAIR
Returns & Efficiency
ROE?
-221.5%WEAK
ROA?
51.3%STRONG
Cash Flow & Enterprise
FCF?$344.9M
Enterprise Value?$2.6B
Related Companies
Loading...
News
Profile
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Employees
435
Market Cap
2.3B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1994-03-03
Address
4505 EMPEROR BOULEVARD
DURHAM, NC 27703
Phone: 919-859-1302